ALZHEIMERS & DEMENTIA

Edit Your Profile

ALZHEIMERS & DEMENTIA Journal

publication venue for

Empowering Communities: Culturally Competent Dementia Awareness Education for Older Adults in Miami‐Dade County. 20:e093012. 2024
The State of the Art in mobile Augmentative and Alternative Communication Devised for People with Dementia: Evaluation of Features and Functions. 20:e094244. 2024
The State of the Art in mobile Augmentative and Alternative Communication Devised for People with Dementia: Evaluation of Features and Functions. 20:e088864. 2024
Utility of Plasma Biomarkers in Screening for Brain Amyloid in the 1Florida Alzheimer Disease Research Center (ADRC). 20:e091578. 2024
Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adults. 20:437-446. 2024
Age‐ and Sex‐ dependent changes in Translocator Protein 18 kDa (TSPO) expression, cellular sources, and association with amyloid‐β plaques in the 5XFAD murine model of Alzheimer’s Disease. 19. 2023
Applying Implementation Frameworks to Health IT Development in Dementia Care: Lessons from the CareHeroes Project. 19. 2023
Applying Implementation Frameworks to Health IT Development in Dementia Care: Lessons from the CareHeroes Project. 19. 2023
Plasma Alzheimer’s Disease Biomarkers and Brain Amyloid in a Multi‐Ethnic Aging Cohort. 19. 2023
The relationship between Structural, PET, and Plasma Alzheimer’s Disease Biomarkers and neuropsychological composites among Latino bilinguals and monolinguals. 19. 2023
The pharmaceutical potential of AR‐65, a novel Alzheimer’s disease drug targeting the immunoproteasome. 18. 2022
Differential discordance of informant‐ and self‐rated depression and apathy in Black, Hispanic, and White participants in the NACC dataset. 17. 2021
Identifying veterans at risk for dementia using claims‐based electronic health record data and machine learning. 17. 2021
Recruitment and retention of culturally diverse older adults into aging research: Investigation planning to explore intergenerational influence. 17. 2021
Age‐friendly initiative needs assessment survey: Los Angeles City and County employees. 16. 2020
Reduced cortical thickness in World Trade Center responders with cognitive impairment. 16. 2020
P1‐153: DDT EXPOSURE INCREASES LEVELS OF THE AMYLOID PRECURSOR PROTEIN, AMYLOID BETA, AND PROINFLAMMATORY FACTORS: MECHANISTIC LINKS TO ALZHEIMER'S DISEASE RISK. 15:p295-p295. 2019
P2‐427: THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS. 15:p775-p776. 2019
P4‐220: EVALUATION OF RESERVE AND RESILIENCE IN THE OLDER SURGICAL PATIENT. 15:p1360-p1361. 2019
P4‐680: A SELECTIVE INHIBITOR OF THE IMMUNOPROTEASOME ATTENUATES DISEASE PROGRESSION IN MOUSE MODELS OF ALZHEIMER'S DISEASE. 15:p1592-p1592. 2019
P1‐365: THE ASSOCIATION OF DEPRESSIVE SYMPTOMS, APATHY, AND ANTIDEPRESSANT USE WITH INCIDENT MCI AND DEMENTIA IN THE NACC DATASET. 14:p434-p435. 2018
P2‐383: CONVERGENCE ANALYSIS OF MICRO‐LESIONS (CAML) FOR DIFFUSE PATHOLOGIES. 14:p844-p845. 2018
P3‐378: EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F‐18] FLORBETABEN. 14:p1237-p1238. 2018
[P1–421]: OPTIMAL NEUROIMAGING MEASURES FOR TRACKING ALZHEIMER's DISEASE PROGRESSION. 13:p438-p440. 2017
[P2–422]: PREDICTING COGNITIVE TEST SCORES IN ALZHEIMER's PATIENTS USING MULTIMODAL LONGITUDINAL DATA. 13:p796-p797. 2017
[P3–554]: PERSISTENT DEPRESSIVE SYMPTOMS AS PARTIAL MEDIATORS IN THE ASSOCIATIONS BETWEEN SUBCLINICAL CARDIOVASCULAR DISEASE WITH ONSET OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA. 13:p1190-p1191. 2017
P3‐190: Relationship between Serum Pesticide Levels and Cognitive Function in Elderly Individuals in the United States: Race/Ethnicity Differences. 12:p894-p894. 2016
P3‐241: Conceptualizing and Individually Predicting Behavioural Variant Frontotemporal Dementia with Meta‐Analyses and Pattern Classification of Imaging Data. 12:p919-p919. 2016
P4‐364: Depressive Symptoms as Potential Mediators of the Associations of Vascular Burden and Subclinical Cardiovascular Disease with Cognitive Decline: Cardiovascular Health Study. 12:p1176-p1177. 2016
O2‐03‐01: Vitamin D and decline in global cognition and memory in the cardiovascular health study. 11:p177-p178. 2015
O2‐03‐02: Vitamin D and the risk of developing neuroimaging abnormalities. 11:p178-p178. 2015
P3‐168: Progression rates from mild cognitive impairment to dementia by biomarker and memory thresholds. 11:p693-p694. 2015
P4‐071: Progression rates to incident mild cognitive impairment by biomarker and memory thresholds. 11:p796-p797. 2015
IC‐P‐003: RELATIONSHIP OF MEDIAL TEMPORAL VOLUME TO MEAN BRAIN AMYLOID CONCENTRATION, APOE GENOTYPE, AND DISEASE STAGE IN ADNI. 10:p8-p9. 2014
IC‐P‐004: THRESHOLDS FOR BRAIN AMYLOID CONCENTRATION IN RELATION TO DISEASE STAGE, COGNITION, BRAIN METABOLISM, BRAIN ATROPHY, AND APOE GENOTYPE IN THE ADNI COHORT. 10:p9-p9. 2014
P4–394: Vitamin D and incident Alzheimer's disease in the Cardiovascular Health Cognition Study. 9:p880-p880. 2013
O4‐07‐03: Pivotal role of the RanBP9‐Cofilin pathway in Aß‐induced apoptosis and neurodegeneration. 8:p627-p628. 2012
P3‐128: A DDT metabolite is elevated in the serum of Alzheimer's disease patients. 8:p496-p496. 2012
O4‐02‐02: Role of the LRP‐RanBP9 pathway in APP processing and Alzheimer's disease susceptibility. 5:p151-p152. 2009
Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases 2022
Alzheimer’s disease diagnosis using gray matter of T1‐weighted sMRI data and vision transformer 2024
Alzheimer’s disease‐associated gene ranking using PhenoGeneRanker 2024
Predicting Individual’s Cognitive Performance Through Multi‐Omics Blood Data Using Hierarchical Input Neural Network ‐ HINN 2024
TA‐RNN: an Attention‐based Time‐aware Recurrent Neural Network Architecture to Predict Progression of Alzheimer’s Disease 2024

category

CLINICAL NEUROLOGY Category

International Standard Serial Number (ISSN)

1552-5260